11.05
price up icon1.28%   0.14
after-market 시간 외 거래: 11.05
loading
전일 마감가:
$10.91
열려 있는:
$10.91
하루 거래량:
169.97K
Relative Volume:
0.63
시가총액:
$530.51M
수익:
$62.02M
순이익/손실:
$-45.65M
주가수익비율:
-12.01
EPS:
-0.92
순현금흐름:
$-9.60M
1주 성능:
+4.44%
1개월 성능:
-0.90%
6개월 성능:
+19.07%
1년 성능:
+32.81%
1일 변동 폭
Value
$10.91
$11.17
1주일 범위
Value
$10.58
$11.44
52주 변동 폭
Value
$7.44
$11.82

Theravance Biopharma Inc Stock (TBPH) Company Profile

Name
명칭
Theravance Biopharma Inc
Name
전화
650-808-6000
Name
주소
UGLAND HOUSE, SOUTH CHURCH STREET, GEORGE TOWN, GRAND CAYMAN
Name
직원
97
Name
트위터
Name
다음 수익 날짜
2024-11-12
Name
최신 SEC 제출 서류
Name
TBPH's Discussions on Twitter

TBPH을(를) 다른 주식과 비교

주식 가격 시가총액 매출 순이익 현금흐름 주당 순 이익
Biotechnology icon
TBPH
Theravance Biopharma Inc
11.05 530.51M 62.02M -45.65M -9.60M -0.92
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
457.03 115.95B 11.10B -988.90M -1.26B -3.92
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
547.74 56.52B 14.09B 4.50B 2.96B 39.28
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
329.77 39.44B 2.35B -269.70M -75.39M -2.09
Biotechnology icon
ARGX
Argen X Se Adr
545.11 35.14B 2.58B 1.06B -1.28B 16.33
Biotechnology icon
ONC
Beone Medicines Ltd Adr
244.32 28.51B 3.81B -644.79M -669.77M -6.24

Theravance Biopharma Inc Stock (TBPH) Upgrades & Downgrades

날짜 액션 분석자 등급 변경
2024-08-06 다운그레이드 Leerink Partners Outperform → Market Perform
2024-04-12 개시 BTIG Research Buy
2024-01-08 다운그레이드 Evercore ISI Outperform → In-line
2022-05-23 개시 SVB Leerink Outperform
2021-11-05 업그레이드 JP Morgan Underweight → Neutral
2021-09-15 다운그레이드 JP Morgan Overweight → Underweight
2021-08-25 다운그레이드 Morgan Stanley Overweight → Underweight
2021-08-24 다운그레이드 Cowen Outperform → Market Perform
2020-10-14 업그레이드 Morgan Stanley Equal-Weight → Overweight
2020-07-07 개시 JP Morgan Overweight
2020-06-15 개시 Morgan Stanley Equal-Weight
2020-05-13 개시 Cowen Outperform
2020-01-08 재확인 H.C. Wainwright Buy
2019-11-06 업그레이드 Robert W. Baird Underperform → Neutral
2019-10-29 개시 H.C. Wainwright Buy
2018-03-29 재개 Piper Jaffray Overweight
2017-08-17 개시 Evercore ISI Outperform
2017-06-16 개시 Cantor Fitzgerald Overweight
2017-05-11 재확인 Needham Buy
2016-12-21 개시 Needham Buy
2016-11-03 개시 Piper Jaffray Overweight
2016-10-12 다운그레이드 Robert W. Baird Neutral → Underperform
2016-08-03 다운그레이드 BofA/Merrill Neutral → Underperform
2016-06-20 개시 Guggenheim Buy
2016-06-20 재확인 Leerink Partners Outperform
2016-05-12 개시 Leerink Partners Outperform
2016-05-05 다운그레이드 BofA/Merrill Buy → Neutral
2015-02-03 업그레이드 Robert W. Baird Underperform → Neutral
모두보기

Theravance Biopharma Inc 주식(TBPH)의 최신 뉴스

pulisher
Jun 18, 2025

Theravance Biopharma (NASDAQ:TBPH) Now Covered by Jones Trading - Defense World

Jun 18, 2025
pulisher
Jun 17, 2025

Theravance Biopharma (TBPH) Receives New Analyst Coverage with a Buy Rating | TBPH Stock News - GuruFocus

Jun 17, 2025
pulisher
Jun 17, 2025

(TBPH) Proactive Strategies - news.stocktradersdaily.com

Jun 17, 2025
pulisher
Jun 16, 2025

Theravance Biopharma (TBPH) Gains Buy Rating with Promising Drug Prospects | TBPH Stock News - GuruFocus

Jun 16, 2025
pulisher
Jun 09, 2025

UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC Buys 32,534 Shares of Theravance Biopharma, Inc. (NASDAQ:TBPH) - Defense World

Jun 09, 2025
pulisher
Jun 06, 2025

Theravance and Mylan settle patent dispute with Eugia Pharma - MSN

Jun 06, 2025
pulisher
Jun 06, 2025

theravance biopharma settles patent litigation with eugia pharma By Investing.com - Investing.com South Africa

Jun 06, 2025
pulisher
Jun 06, 2025

Theravance and Viatris settle patent dispute with Eugia Pharma - Seeking Alpha

Jun 06, 2025
pulisher
Jun 06, 2025

Theravance BiopharmaTheravance And Mylan Enter Settlement Agreement With EugiaSEC Filing - MarketScreener

Jun 06, 2025
pulisher
Jun 06, 2025

Theravance Biopharma Settles Patent Litigation with Eugia - TipRanks

Jun 06, 2025
pulisher
Jun 06, 2025

theravance biopharma settles patent litigation with eugia pharma - Investing.com

Jun 06, 2025
pulisher
Jun 05, 2025

Theravance Biopharma Sells Remaining Trelegy Royalties to GSK for $225 Million - Global Legal Chronicle

Jun 05, 2025
pulisher
Jun 04, 2025

(TBPH) Investment Analysis - news.stocktradersdaily.com

Jun 04, 2025
pulisher
Jun 03, 2025

TBPH to Sell Remaining Trelegy Royalty Interest to GSK, Stock Rises - sharewise

Jun 03, 2025
pulisher
Jun 03, 2025

ProShare Advisors LLC Takes Position in Theravance Biopharma, Inc. (NASDAQ:TBPH) - Defense World

Jun 03, 2025
pulisher
Jun 03, 2025

Theravance Biopharma, Inc. (NASDAQ:TBPH) Shares Bought by Millennium Management LLC - Defense World

Jun 03, 2025
pulisher
Jun 02, 2025

Theravance Biopharma Sells Remaining Royalty Interest in Trelegy Ellipta to GSK for $225 Million - marketscreener.com

Jun 02, 2025
pulisher
Jun 02, 2025

Theravance Biopharma Sells Trelegy Royalty Interest to GSK - TipRanks

Jun 02, 2025
pulisher
Jun 02, 2025

Theravance Biopharma, Inc. Sells Remaining Royalty Interest in T - GuruFocus

Jun 02, 2025
pulisher
Jun 02, 2025

Theravance Biopharma, Inc. Sells Remaining Royalty Interest in Trelegy Ellipta to GSK for $225 Million - Eagle-Tribune

Jun 02, 2025
pulisher
Jun 02, 2025

Ameriprise Financial Inc. Cuts Stake in Theravance Biopharma, Inc. (NASDAQ:TBPH) - Defense World

Jun 02, 2025
pulisher
Jun 01, 2025

Nuveen Asset Management LLC Buys 48,635 Shares of Theravance Biopharma, Inc. (NASDAQ:TBPH) - Defense World

Jun 01, 2025
pulisher
May 30, 2025

Deutsche Bank AG Purchases 15,608 Shares of Theravance Biopharma, Inc. (NASDAQ:TBPH) - Defense World

May 30, 2025
pulisher
May 30, 2025

Jane Street Group LLC Has $493,000 Stock Position in Theravance Biopharma, Inc. (NASDAQ:TBPH) - Defense World

May 30, 2025
pulisher
May 29, 2025

Bank of America Corp DE Increases Holdings in Theravance Biopharma, Inc. (NASDAQ:TBPH) - Defense World

May 29, 2025
pulisher
May 28, 2025

Theravance Biopharma to Present New Ampreloxetine Data at the 2023 International Congress of Parkinson's Disease and Movement Disorders - Barchart.com

May 28, 2025
pulisher
May 25, 2025

(TBPH) On The My Stocks Page - news.stocktradersdaily.com

May 25, 2025
pulisher
May 23, 2025

Northern Trust Corp Has $3.67 Million Stock Position in Theravance Biopharma, Inc. (NASDAQ:TBPH) - Defense World

May 23, 2025
pulisher
May 21, 2025

The past five years for Theravance Biopharma (NASDAQ:TBPH) investors has not been profitable - Yahoo Finance

May 21, 2025
pulisher
May 20, 2025

Theravance Biopharma at H.C. Wainwright: Strategic Focus on YUPELRI and Ampreloxetine - Investing.com Canada

May 20, 2025
pulisher
May 16, 2025

Theravance Biopharma (NASDAQ:TBPH) Stock Rating Upgraded by StockNews.com - Defense World

May 16, 2025
pulisher
May 15, 2025

When (TBPH) Moves Investors should Listen - news.stocktradersdaily.com

May 15, 2025
pulisher
May 13, 2025

Theravance Biopharma to Participate in an Upcoming Investor Conf - GuruFocus

May 13, 2025
pulisher
May 13, 2025

Theravance Biopharma to Participate in an Upcoming Investor Conference - Citizen Tribune

May 13, 2025
pulisher
May 13, 2025

Price T Rowe Associates Inc. MD Buys 9,315 Shares of Theravance Biopharma, Inc. (NASDAQ:TBPH) - Defense World

May 13, 2025
pulisher
May 13, 2025

Dimensional Fund Advisors LP Acquires 95,304 Shares of Theravance Biopharma, Inc. (NASDAQ:TBPH) - Defense World

May 13, 2025
pulisher
May 12, 2025

We Think Some Shareholders May Hesitate To Increase Theravance Biopharma, Inc.'s (NASDAQ:TBPH) CEO Compensation - simplywall.st

May 12, 2025
pulisher
May 10, 2025

Theravance Biopharma, Inc. (NASDAQ:TBPH) Q1 2025 Earnings Call Transcript - Insider Monkey

May 10, 2025
pulisher
May 09, 2025

Theravance Biopharma Announces Ampreloxetine Presentations at th - GuruFocus

May 09, 2025
pulisher
May 09, 2025

Theravance Biopharma, Inc. Announces Ampreloxetine Presentations At the International MSA Congress - marketscreener.com

May 09, 2025
pulisher
May 09, 2025

Theravance's Q1 Loss Wider Than Expected, Revenues Rise Y/Y - TradingView

May 09, 2025
pulisher
May 09, 2025

Theravance Biopharma Announces Ampreloxetine Presentations at the International MSA Congress | TBPH Stock News - GuruFocus

May 09, 2025
pulisher
May 09, 2025

Theravance Biopharma Announces Ampreloxetine Presentations at the International MSA Congress - Stock Titan

May 09, 2025
pulisher
May 09, 2025

Theravance Biopharma: Promising Future with Strong Product Pipeline and Market Expansion - TipRanks

May 09, 2025
pulisher
May 09, 2025

Theravance Biopharma Inc (TBPH) Q1 2025 Earnings Call Highlights - GuruFocus

May 09, 2025
pulisher
May 09, 2025

Tower Research Capital LLC TRC Increases Position in Theravance Biopharma, Inc. (NASDAQ:TBPH) - The AM Reporter

May 09, 2025
pulisher
May 09, 2025

Wells Fargo & Company MN Has $204,000 Holdings in Theravance Biopharma, Inc. (NASDAQ:TBPH) - Defense World

May 09, 2025
pulisher
May 09, 2025

Theravance Biopharma Inc (TBPH) Q1 2025 Earnings Call Highlights: Strong Sales Growth and ... - Yahoo Finance

May 09, 2025
pulisher
May 09, 2025

Theravance Biopharma Inc (TBPH) Q1 2025 Earnings Call Highlights: Strong Sales Growth and Strategic Progress Amid Challenges - GuruFocus

May 09, 2025
pulisher
May 09, 2025

Theravance Biopharma Reports Q1 2025 Financial Results - TipRanks

May 09, 2025
pulisher
May 09, 2025

Earnings call transcript: Theravance Biopharma misses Q1 2025 EPS forecast - Investing.com

May 09, 2025

Theravance Biopharma Inc (TBPH) 재무 분석

매출

loading

순이익

loading

현금흐름

loading

주당 순 이익

loading
$20.44
price down icon 1.45%
$36.19
price up icon 0.86%
$22.62
price up icon 6.70%
$98.24
price up icon 0.64%
$108.26
price up icon 0.70%
biotechnology ONC
$244.32
price down icon 0.34%
자본화:     |  볼륨(24시간):